Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections.
Read moreAnnual Revenue
$8.2M
Aligos Therapeutics's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 5.4M. Over the last four quarters, Aligos Therapeutics's revenue has grown by 140.3%. Specifically, in Q2 2022's revenue was $3.7M; in Q1 2022, it was $2.6M; in Q4 2021, it was $ < 1M; in Q3 2021, Aligos Therapeutics's revenue was $1.5M.
1 Corporate Drive 2nd Floor
San Francisco, California94080
Driving Directions »